Stay updated on Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.

Latest updates to the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a new revision marker (v3.6.5) replacing the previous one, indicating a small site update without changing the study information.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.6.4 replaces v3.6.3, indicating the page version was updated. This is a metadata update rather than a content change.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now shows a new revision tag v3.6.3, replacing the previous v3.6.2. This indicates a small update to the page's metadata/versioning without changes to the study data or visible content.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2. This indicates a newer version of the page rendering, typically reflecting small maintenance updates to metadata or formatting.SummaryDifference0.1%

- Check68 days agoChange DetectedNew navigation/help sections were added and the Intervention/Treatment header was standardized (Intervention / Treatment to Intervention/Treatment), and the Revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check75 days agoChange DetectedThe footer now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating a small page/version update. This change is metadata-related and does not modify the study information or user workflow.SummaryDifference0.1%

Stay in the know with updates to Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.